Mattson Financial Services LLC boosted its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 9.0% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,892 shares of the company's stock after buying an additional 1,728 shares during the quarter. Procter & Gamble accounts for about 1.1% of Mattson Financial Services LLC's holdings, making the stock its 25th biggest holding. Mattson Financial Services LLC's holdings in Procter & Gamble were worth $3,560,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds also recently bought and sold shares of PG. Nuveen LLC purchased a new position in shares of Procter & Gamble in the first quarter valued at approximately $1,954,941,000. GAMMA Investing LLC boosted its stake in shares of Procter & Gamble by 20,758.5% in the first quarter. GAMMA Investing LLC now owns 7,951,456 shares of the company's stock valued at $1,355,087,000 after purchasing an additional 7,913,335 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of Procter & Gamble by 13.0% in the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares during the period. Invesco Ltd. boosted its stake in shares of Procter & Gamble by 19.8% in the first quarter. Invesco Ltd. now owns 13,493,604 shares of the company's stock valued at $2,299,580,000 after purchasing an additional 2,228,151 shares during the period. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its stake in shares of Procter & Gamble by 15.8% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 16,274,563 shares of the company's stock valued at $2,728,430,000 after purchasing an additional 2,224,912 shares during the period. Hedge funds and other institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Down 1.2%
Shares of NYSE:PG opened at $157.49 on Thursday. The firm's 50 day moving average price is $156.30 and its 200 day moving average price is $162.09. The stock has a market cap of $368.59 billion, a price-to-earnings ratio of 24.19, a price-to-earnings-growth ratio of 4.21 and a beta of 0.36. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The company has a quick ratio of 0.49, a current ratio of 0.70 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. The firm had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm's revenue was up 1.7% compared to the same quarter last year. During the same quarter last year, the company earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts predict that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a yield of 2.7%. Procter & Gamble's dividend payout ratio (DPR) is presently 64.98%.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, insider Susan Street Whaley sold 1,000 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $156.84, for a total transaction of $156,840.00. Following the sale, the insider owned 28,436 shares of the company's stock, valued at approximately $4,459,902.24. This trade represents a 3.40% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Gary A. Coombe sold 10,194 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total transaction of $1,612,283.04. Following the sale, the chief executive officer directly owned 34,978 shares in the company, valued at approximately $5,532,120.48. The trade was a 22.57% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 120,181 shares of company stock valued at $18,918,012 in the last quarter. Company insiders own 0.20% of the company's stock.
Wall Street Analyst Weigh In
Several research firms have recently commented on PG. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $170.00 price objective (down previously from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Wells Fargo & Company lowered their price objective on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Evercore ISI reissued an "in-line" rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Barclays set a $164.00 price objective on shares of Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Finally, UBS Group set a $180.00 target price on shares of Procter & Gamble and gave the company a "buy" rating in a report on Wednesday, July 30th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $175.12.
Read Our Latest Stock Analysis on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report